Abstract
(Abstracted from Am J Med Genet 2018;176A:376–385) Rapid, affordable genome sequencing in reproductive medicine continues to increase in availability and popularity, with some commercial laboratories now offering expanded carrier panels for all patients. This trend presents clinicians with new challenges in presentation and supporting patients’ decisions as they decide whether to receive expanded, genome-scale carrier screening.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
